Regenxbio Inc’s recently made public that its Chief Executive Officer Simpson Curran unloaded Company’s shares for reported $77495.0 on Sep 10 ’25. In the deal valued at $10.02 per share,7,734 shares were sold. As a result of this transaction, Simpson Curran now holds 244,597 shares worth roughly $2.17 million.
Then, CURRAN M SIMPSON bought 15,358 shares, generating $151,891 in total proceeds.
Before that, Mills Kenneth T. sold 20,602 shares. Regenxbio Inc shares valued at $163,046 were divested by the Director at a price of $7.91 per share. As a result of the transaction, Mills Kenneth T. now holds 475,103 shares, worth roughly $4.22 million.
Goldman downgraded its Regenxbio Inc [RGNX] rating to a Neutral from a a Buy in a research note published on February 11, 2025; the price target was decreased to $14 from $38.
Price Performance Review of RGNX
On Friday, Regenxbio Inc [NASDAQ:RGNX] saw its stock fall -5.02% to $8.89. Over the last five days, the stock has lost -3.37%. Regenxbio Inc shares have fallen nearly -31.35% since the year began. Nevertheless, the stocks have risen 15.01% over the past one year.
How much short interest is there in Regenxbio Inc?
A steep rise in short interest was recorded in Regenxbio Inc stocks on 2025-08-29, dropping by -0.35 million shares to a total of 5.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 5.48 million shares. There was a decline of -6.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 07, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $38 price target.
